Description of Conduct

On 2 July 2014 Medicines Australia sought re-authorisation in respect of Edition 18 of the Medicines Australia Code of Conduct, which is a voluntary industry code of conduct for the prescription medicines industry in Australia.

On 24 April 2015 the ACCC issued a final determination granting conditional authorisation for a period of five years.

In edition 18 of the Code, Medicines Australia proposed to require its member pharmaceutical companies to report certain benefits made to individual healthcare professionals. The conditions of authorisation require:
-Medicines Australia member companies to ensure, before providing a relevant benefit to a healthcare professional, that the benefit will be able to be individually reported
-the transparency data to be published in a common accessible format
-the transparency data to be made publicly available for at least three years from the date of first publication
-Medicines Australia to use reasonable endeavours to establish a central reporting system for reporting this transparency data and provide regular reports on its progress in doing so.

A copy of the determination is available by following the links below.

Applicant(s)

  • Medicines Australia Limited

Authorisation number(s)

  • A91436
  • A91437
  • A91438
  • A91439
  • A91440

Applications

Submissions - before draft decision

Document title Date
Professor Philip Morris
Applicant
Dr Ken Harvey
Applicant
Applicant
Department of Health
Professor Philip Morris
Applicant
Australian Society of Anaesthetists
Nikita Kotlarov
Dr Ken Harvey
Royal Australian College of General Practitioners
Cancer Voices Australia
Pfizer Australia
Associate Professor Barbara Mintzes
Applicant
South Australian Medicines Advisory Committee
Dr Agnes Vitry
Dr Robert Purssey
The Society of Hospital Pharmacists of Australia
Pharmaceutical Society of Australia
Australian Primary Healthcare Nurses Association
The Pharmacy Guild of Australia
Consumers Health Forum of Australia
The Royal Australian & New Zealand College of Psychiatrists
Professor Philip Morris
Dr Elissa Campbell
Professor Peter S. Schonhofer
Dr Tim Woodruff
CHOICE
Professor Ian Haines
Jarrod McMaugh
GlaxoSmithKline Australia Pty Ltd
Australian Medical Association
Sean Israel
Professor Alastair MacLennan
Professor Marcello Costa
Therapeutic Guidelines Limited
Alison Marcus
Roseanne Peel
Peter Sainsbury
John Braithwaite
Ross Gubbels
Margot Murphy
Dan Kent
Dr Mary Osborn
John TD Wood
Joel Lexchin
Robin M G Brown
Peter Bayly
Kerry Holmes
Jon Jureidini
Stuart Anderson
Ken Harvey
Geoff Kirwood
Merck Sharp & Dohme (Australia) Pty Limited
Dr Rob McEvoy
Dr Geoff Smith
Shane Carney
Medicines Australia & Privacy Commissioner - &
Show all documents (57 more)

Submissions - after draft decision

Document title Date
Dr Rob McEvoy
Applicant; Acceptance of Conditions
Applicant
Applicant
Australian Privacy Commissioner
Consumers Health Forum of Australia
ASCEPT
Applicant
Applicant
The Society of Hospital Pharmacists of Australia
Royal Australian College of General Practitioners
Pfizer Australia
Australian Medical Association ?
Royal Australian and New Zealand College of Psychiatrists ?
Australian Society of Anaesthetists
Dr Robert Purssey
Dr Geoff Smith
Dr Ken Harvey
Chris Del Mar
Professor Philip Morris
Applicant
Professor Phiip Morris
Applicant
Public Health Association of Australia
Professor Philip Morris
Bristol-Myers Squibb Australia
Public Health Association of Australia
Pfizer Australia
Celgene Pty Ltd
Professor Phillip Morris
Novo Nordisk Pharmaceuticals Pty Ltd
ASCEPT
Applicant
Consumers Health Forum of Australia
Australian Medical Association ?
Sanofi-Aventis Australia Pty Ltd
Merck Sharp & Dohme (Australia) Pty Limited
Associate Professor Richard O'Brien
Royal Australian College of General Practitioners
Dr Ken Harvey
Royal Australian and New Zealand College of Psychiatrists
Privacy Commissioner
Geoff Kirwood
Cancer Voices Australia
The Society of Hospital Pharmacists of Australia (SHPA)
AMA
Chris Del Mar
Dr Geoff Smith
Show all documents (45 more)